Timeline

Sylvie van Der Werf

Head of Structure

08 Sep 2023

publication

Genotype and Phenotype Characterization of Rhinolophus sp. Sarbecoviruses from Vietnam: Implications for Coronavirus Emergence.

21 Apr 2023

publication

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.

05 Apr 2023

publication

SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19

15 Mar 2023

project

CoVariant – Comprendre les déterminants de l’immunité muqueuse et optimiser le diagnostic de l’infection aux variants du SARS-CoV-2

07 Feb 2023

publication

High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing.

01 Sep 2022

publication

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

15 Jul 2022

publication

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1

15 Jul 2022

publication

C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus.

04 Jul 2022

publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

17 Jun 2022

news

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

04 May 2022

publication

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.

14 Apr 2022

publication

Bat coronaviruses related to SARS-CoV-2 and infectious for human cells.

22 Dec 2021

publication

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs

16 Dec 2021

publication

A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.

14 Dec 2021

project

Towards understanding of immunostimulatory properties of SARS-CoV-2 RNAs

01 Sep 2021

publication

Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.

26 Jul 2021

news

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

22 Jul 2021

publication

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.

21 May 2021

publication

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.

20 Jan 2021

publication

Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification

01 Dec 2020

publication

Syncytia formation by SARS-CoV-2-infected cells.

06 Nov 2020

news

Suivi de la persistance de la réponse immunitaire contre le SARS-CoV-2 au sein de la cohorte de Crépy-en-Valois (COVID-Oise)

22 Sep 2020

publication

Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription.

02 Sep 2020

publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

04 Aug 2020

publication

Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.

01 Jul 2020

publication

Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.

02 Apr 2020

project

The European Virus Archive Goes Global

31 Jan 2020

news

Coronavirus : Mobilisation Equipes de l’Institut Pasteur

28 Jan 2020

news

Coronavirus de Wuhan

19 Oct 2017

publication

Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms

03 Jul 2015

project

Epidemiology and evolution of respiratory viruses

30 Sep 2014

publication

Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulation

21 Nov 2013

publication

The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expression

13 Nov 2013

publication

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

05 Nov 2013

publication

Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses

19 Jun 2013

publication

Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models

15 Dec 2012

publication

Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network

13 May 2009

publication

April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission

30 Oct 2008

publication

Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes

08 Aug 2007

publication

Rescue of influenza C virus from recombinant DNA

29 May 2007

publication

Influenza A/H5N1 virus infection in humans in Cambodia

01 Jan 2007

publication

Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.

03 Nov 2005

publication

Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5′ terminal sequence: induction of heterospecific B and T cell responses in mice

01 Nov 2005

publication

Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells

10 Oct 2005

publication

The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment

15 Aug 2003

publication

Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter

16 May 2003

publication

A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice.

25 Nov 2002

publication

Differential effect of nucleotide substitutions in the 3′ arm of the influenza A virus vRNA promoter on transcription/replication by avian and human polymerase complexes is related to the nature of PB2 amino acid 627

01 May 2002

publication

A little guide for advanced search:

Genotype and Phenotype Characterization of Rhinolophus sp. Sarbecoviruses from Vietnam: Implications for Coronavirus Emergence.

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.

SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19

CoVariant – Comprendre les déterminants de l’immunité muqueuse et optimiser le diagnostic de l’infection aux variants du SARS-CoV-2

High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing.

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1

C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus.

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.

Bat coronaviruses related to SARS-CoV-2 and infectious for human cells.

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs

A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.

Towards understanding of immunostimulatory properties of SARS-CoV-2 RNAs

Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.

Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification

Syncytia formation by SARS-CoV-2-infected cells.

Suivi de la persistance de la réponse immunitaire contre le SARS-CoV-2 au sein de la cohorte de Crépy-en-Valois (COVID-Oise)

Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription.

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.

Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.

The European Virus Archive Goes Global

Coronavirus : Mobilisation Equipes de l’Institut Pasteur

Coronavirus de Wuhan

Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms

Epidemiology and evolution of respiratory viruses

Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulation

The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expression

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses

Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models

Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network

April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission

Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes

Rescue of influenza C virus from recombinant DNA

Influenza A/H5N1 virus infection in humans in Cambodia

Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.

Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5′ terminal sequence: induction of heterospecific B and T cell responses in mice

Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells

The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment

Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter

A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice.

Differential effect of nucleotide substitutions in the 3′ arm of the influenza A virus vRNA promoter on transcription/replication by avian and human polymerase complexes is related to the nature of PB2 amino acid 627

Expression of a membrane-anchored glycoprotein, the influenza virus hemagglutinin, by dicistronic replicons derived from the poliovirus genome